Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events-Reference-Cited by-同舟云学术

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events

Published:2020-03 Issue:3 Volume:11 Page:799-804
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Zhuang Junling¹^ORCID,Du Jianhua¹^ORCID,Guo Xiaoxiao²^ORCID,Zhou Jiaxin³^ORCID,Duan Lian⁴,Qiu Wei⁵,Si Xiaoyan⁶^ORCID,Zhang Li⁷,Li Yue⁸,Liu Xiaowei⁹,Wang Hanping⁶^ORCID,Zhou Daobin¹,Zhang Li⁶

Affiliation:

1. Department of HematologyPeking Union Medical College Hospital Beijing China

2. Department of CardiologyPeking Union Medical College Hospital Beijing China

3. Department of RheumatologyPeking Union Medical College Hospital Beijing China

4. Department of EndocrinologyPeking Union Medical College Hospital Beijing China

5. Department of NephrologyPeking Union Medical College Hospital Beijing China

6. Department of Respiratory MedicinePeking Union Medical College Hospital Beijing China

7. Department of Clinical LaboratoryPeking Union Medical College Hospital Beijing China

8. Department of GastroenterologyPeking Union Medical College Hospital Beijing China

9. Department of OphthalmologyPeking Union Medical College Hospital Beijing China

Funder

Natural Science Funds of the Beijing Municipality

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13281

Reference32 articles.

1. Hallmarks of Cancer: The Next Generation

3. Haematological toxicities with immunotherapy in patients with cancer: a systematic review and meta-analysis

4. Hemophilia A Induced by Ipilimumab

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of emergency department visits and immune-related adverse effects (irAEs) in patients treated with nivolumab;Supportive Care in Cancer;2024-09-09

2. A Case of Immune Aplastic Anemia during Combined Treatment with Atezolizumab and Chemotherapy for Non-Small Cell Lung Cancer;Journal of Nippon Medical School;2024-06-25

3. The Potential Adverse Impact of Post-Treatment Thrombocytopenia on Clinical Outcomes in Cancer Patients Treated With Immune Checkpoint Inhibitors;Cureus;2024-06-11

4. First reported use of immune checkpoint inhibitor for treatment of cancer in a patient with acquired hemophilia A;Clinical Immunology Communications;2024-06

5. Efficacy and Safety of Hetrombopag for Thrombocytopenia in Patients with Advanced Solid Tumors: A Retrospective Study;Journal of Clinical Pharmacy and Therapeutics;2023-12-30